Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Arulnaden

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annales De Medecine Interne|January 1, 1982
[Type II familial hyperlipoproteinaemia : value of plasma exchange treatment (author's transl)]F Jan, R Sylvestre, B Jacotot, et al.
Lancet (London, England)|April 6, 1991
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patientsD Samuel, A Bismuth, D Mathieu, et al.
Transplantation|April 27, 1995
The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patientsO Farges, A N Kalil, D Samuel, et al.
Journal of Hepatology|March 1, 1997
De novo and apparent de novo hepatitis B virus infection after liver transplantationB Roche, D Samuel, M Gigou, et al.
Hepatology (Baltimore, Md.)|February 1, 1995
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitisD Samuel, A L Zignego, M Reynes, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|March 1, 1992
[Relapse prevention in liver transplant patients treated for liver involvement due to hepatitis B virus]A Bismuth, J L Arulnaden, D Samuel, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|December 1, 1991
[Liver transplantation and the major histocompatibility complex]A Bismuth, B Ducot, D Samuel, et al.
Hepatology (Baltimore, Md.)|January 1, 1994
Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver diseaseP Marcellin, D Samuel, J Areias, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annales De Medecine Interne|January 1, 1982
[Type II familial hyperlipoproteinaemia : value of plasma exchange treatment (author's transl)]F Jan, R Sylvestre, B Jacotot, et al.
Lancet (London, England)|April 6, 1991
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patientsD Samuel, A Bismuth, D Mathieu, et al.
Transplantation|April 27, 1995
The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patientsO Farges, A N Kalil, D Samuel, et al.
Journal of Hepatology|March 1, 1997
De novo and apparent de novo hepatitis B virus infection after liver transplantationB Roche, D Samuel, M Gigou, et al.
Hepatology (Baltimore, Md.)|February 1, 1995
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitisD Samuel, A L Zignego, M Reynes, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|March 1, 1992
[Relapse prevention in liver transplant patients treated for liver involvement due to hepatitis B virus]A Bismuth, J L Arulnaden, D Samuel, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|December 1, 1991
[Liver transplantation and the major histocompatibility complex]A Bismuth, B Ducot, D Samuel, et al.
Hepatology (Baltimore, Md.)|January 1, 1994
Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver diseaseP Marcellin, D Samuel, J Areias, et al.
Pageof 1